Quest Diagnostics Incorporated (DGX)
NYSE: DGX · Real-Time Price · USD
173.94
-1.93 (-1.10%)
Apr 25, 2025, 11:53 AM EDT - Market open
Quest Diagnostics Revenue
Quest Diagnostics had revenue of $2.65B in the quarter ending March 31, 2025, with 12.09% growth. This brings the company's revenue in the last twelve months to $10.16B, up 9.38% year-over-year. In the year 2024, Quest Diagnostics had annual revenue of $9.87B with 6.70% growth.
Revenue (ttm)
$10.16B
Revenue Growth
+9.38%
P/S Ratio
1.92
Revenue / Employee
$181,393
Employees
56,000
Market Cap
19.42B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 9.87B | 620.00M | 6.70% |
Dec 31, 2023 | 9.25B | -631.00M | -6.38% |
Dec 31, 2022 | 9.88B | -905.00M | -8.39% |
Dec 31, 2021 | 10.79B | 1.35B | 14.32% |
Dec 31, 2020 | 9.44B | 1.71B | 22.15% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.90B |
DGX News
- 1 day ago - These Analysts Boost Their Forecasts On Quest Diagnostics After Better-Than-Expected Q1 Earnings - Benzinga
- 3 days ago - Quest Diagnostics Revenue Rebound, Strategic Moves Fuel Outlook Confidence - Benzinga
- 3 days ago - Quest Diagnostics Incorporated (DGX) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 3 days ago - Quest beats quarterly profit estimates on strong demand for diagnostic tests - Reuters
- 3 days ago - Quest Diagnostics earnings beat after March rebound in demand from slump early in the quarter - Market Watch
- 3 days ago - Quest Diagnostics Reports First Quarter 2025 Financial Results; Reaffirms Revenue and Adjusted Diluted EPS Guidance for Full Year 2025 - PRNewsWire
- 16 days ago - Quest Diagnostics Launches New AD-Detect™ Blood Test to Aid in Confirming Alzheimer's Disease - PRNewsWire
- 20 days ago - 8 Upcoming Dividend Increases During Volatile Times - Seeking Alpha